Cole Matthew D, Jakowatz James, Evans Gregory R D
Division of Plastic Surgery and Surgical Oncology, The University of California, Irvine, Orange 92868, USA.
Plast Reconstr Surg. 2003 Jul;112(1):50-6. doi: 10.1097/01.PRS.0000065913.11455.15.
Treatment of malignant melanoma of the external ear presents unique challenges. Because of the significant debate regarding the efficacy and validity of using sentinel lymph node mapping for the treatment of ear melanomas, data for a population of patients with melanomas of the ear who underwent surgical excision and reconstruction were reviewed to determine the efficacy of sentinel node mapping. A retrospective chart review of cases treated by a single surgical oncologist was performed. All patients who were treated for malignant melanomas and required reconstruction of the external ear by the plastic surgical service between 1995 and 2001 were identified. Nineteen patients were selected, of whom nine underwent sentinel node mapping. The average age of the patients was 65.2 years. Evaluation of melanoma depth, medical history, surgical margins, lymph node metastasis, and recurrence was performed. Lymphoscintigraphy with technetium-99-sulfur colloid and 1% Lymphazurin (isosulfan blue; Zenith Parenterals, Rosemont, Ill.) demonstrated widely variable lymphatic drainage patterns. The lower tail of the parotid gland and the upper cervical area were the two most common locations. The average number of sentinel nodes identified and removed was 3.7. The average Breslow thickness for these patients was 2.3 mm. None of these patients demonstrated micrometastatic disease in their sentinel nodes. The most common reconstructive procedure after surgical resection was the use of rotational advancement flaps. Localization of radioactivity, as detected with external technetium-99 scanning, was the most reliable method for detection of the sentinel lymph node basins and the individual nodes. The average value for the primary injection site was 8375 counts per second, and the average value for the nodes removed was 973.5 counts per second. Of the nine patients who underwent sentinel lymph node mapping, only one, with an initial lesion depth of 5 mm, developed a local recurrence. The average follow-up period in this study was 21 months (range, 12 to 79 months). All patients in this study were evaluated at least 1 year after the initial surgical resection. Patients were monitored by the same surgical oncologist every 3 months for the first 2 years. Little can be found in the literature regarding the efficacy of sentinel node biopsies for ear melanomas. Larger studies are indicated; however, it seems that this method is practical for designing therapeutic methods for patients with melanoma of the ear.
外耳道恶性黑色素瘤的治疗面临着独特的挑战。由于对于前哨淋巴结图谱法用于耳部黑色素瘤治疗的有效性和正确性存在重大争议,因此回顾了一组接受手术切除和重建的耳部黑色素瘤患者的数据,以确定前哨淋巴结图谱法的疗效。对由一位外科肿瘤学家治疗的病例进行了回顾性图表分析。确定了1995年至2001年间所有接受恶性黑色素瘤治疗且需要整形外科进行外耳道重建的患者。选择了19例患者,其中9例接受了前哨淋巴结图谱法检查。患者的平均年龄为65.2岁。对黑色素瘤深度、病史、手术切缘、淋巴结转移和复发情况进行了评估。使用锝-99-硫胶体和1% 亚甲蓝(异硫蓝;Zenith Parenterals公司,伊利诺伊州罗斯蒙特)进行的淋巴闪烁显像显示出广泛不同的淋巴引流模式。腮腺下极和颈上部区域是两个最常见的部位。识别并切除的前哨淋巴结平均数量为3.7个。这些患者的平均Breslow厚度为2.3毫米。这些患者中没有一例在前哨淋巴结中显示微转移疾病。手术切除后最常见的重建方法是使用旋转推进皮瓣。通过外部锝-99扫描检测到的放射性定位是检测前哨淋巴结区域和单个淋巴结最可靠的方法。原发注射部位的平均值为每秒8375计数,切除淋巴结的平均值为每秒973.5计数。在接受前哨淋巴结图谱法检查的9例患者中,只有1例初始病变深度为5毫米的患者出现了局部复发。本研究的平均随访期为21个月(范围为12至79个月)。本研究中的所有患者在初次手术切除后至少1年进行了评估。在最初的2年中,由同一位外科肿瘤学家每3个月对患者进行一次监测。关于前哨淋巴结活检用于耳部黑色素瘤的疗效,在文献中几乎找不到相关内容。需要进行更大规模的研究;然而,这种方法似乎对于为耳部黑色素瘤患者设计治疗方法是切实可行的。